[1]
C. Eze, Y. Hussein Agha, and B. Duran, “Favorable Outcomes Following the Use of Triple Therapy in a Patient with Osmotic Demyelination Syndrome”, kjm, vol. 13, no. 1, pp. 191–193, Jul. 2020, doi: 10.17161/kjm.v13i.13875.